Result Type

You Searched For:

6,197  results were found

Spectrocolorimètres et impuretés analytiques pharmaceutiques USP

Spectrocolorimètres et impuretés analytiques pharmaceutiques USP Depuis plus de 200 ans l’USP (United States Pharmacopoeia) travaille à établir la confiance dans les domaines où elle revêt une importance capitale : les médicaments les compléments ...

Sugars and carbohydrates compendial and multi compendial

Sugars and carbohydrates compendial and multi compendial Innovations Key carbohydrates for bioprocessing Biopharmaceutical production often uses carbohydrates at different stages of the process, notably fermentation , cell culture or formulation. ...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

VWR creates NEW multi-compendial carbohydrates

VWR creates NEW multi-compendial carbohydrates Introduction price! New sugars such as glucose anhydrous Ph. Eur. and USP (28450*) glucose hydrated Ph. Eur. (24369*) or fructose Ph. Eur. (24282*) The requirements and regulations faced by manufactur...

Avantor biopharma videos

Avantor biopharma videos mAbs scale up solutions Avantor single-use assurance of supply Avantor Seradigm OmniTop Assemblies Fluid Transfer Demo Avantor Single-Use Solutions J.T.Baker® Direct Dispense Solutions Cell & Gene Therapy Solutions Avantor...

Avantor biopharma videos

Avantor biopharma videos mAbs scale up solutions Avantor single-use assurance of supply Avantor Seradigm OmniTop Assemblies Fluid Transfer Demo Avantor Single-Use Solutions J.T.Baker® Direct Dispense Solutions Cell & Gene Therapy Solutions Avantor...

Avantor biopharma videos

Avantor biopharma videos mAbs scale up solutions Avantor single-use assurance of supply Avantor Seradigm OmniTop Assemblies Fluid Transfer Demo Avantor Single-Use Solutions J.T.Baker® Direct Dispense Solutions Cell & Gene Therapy Solutions Avantor...

Avantor biopharma videos

Avantor biopharma videos mAbs scale up solutions Avantor single-use assurance of supply Avantor Seradigm OmniTop Assemblies Fluid Transfer Demo Avantor Single-Use Solutions J.T.Baker® Direct Dispense Solutions Cell & Gene Therapy Solutions Avantor...

Avantor biopharma videos

Avantor biopharma videos mAbs scale up solutions Avantor single-use assurance of supply Avantor Seradigm OmniTop Assemblies Fluid Transfer Demo Avantor Single-Use Solutions J.T.Baker® Direct Dispense Solutions Cell & Gene Therapy Solutions Avantor...

Avantor biopharma videos

Avantor biopharma videos mAbs scale up solutions Avantor single-use assurance of supply Avantor Seradigm OmniTop Assemblies Fluid Transfer Demo Avantor Single-Use Solutions J.T.Baker® Direct Dispense Solutions Cell & Gene Therapy Solutions Avantor...

Avantor biopharma videos

Avantor biopharma videos mAbs scale up solutions Avantor single-use assurance of supply Avantor Seradigm OmniTop Assemblies Fluid Transfer Demo Avantor Single-Use Solutions J.T.Baker® Direct Dispense Solutions Cell & Gene Therapy Solutions Avantor...

Advancing next gen biologic manufacturing by implementing continuous downstream processing platform

Advancing next gen biologic manufacturing by implementing continuous downstream processing platform An integrated downstream process is needed to efficiently support ever increasing pipeline and demand of mAbs in clinical development. In spite of ...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
-79 - -64 of 6,197